The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for kidney function decline, […]
AstraZeneca’s Diabetes Drug Farxiga Fails in COVID-19 Study
(Reuters) – Data from a late-stage study to test if AstraZeneca’s diabetes drug Farxiga could treat patients hospitalised with COVID-19 […]
NPWT May Not Improve Complication Rate After Gynecologic Surgery
Use of prophylactic negative pressure wound therapy may not be appropriate in surgical cases where women undergo a laparotomy for […]
Metformin May Be Beneficial for Children With Obesity
NEW YORK (Reuters Health) – Metformin had “modest” beneficial effects on weight and insulin resistance among obese young children in […]
Lipodystrophy Causes
Lipodystrophy is a fat metabolism error, which manifests clinically in the form of excessive fat deposition in some areas such […]